Yipinhong Pharmaceutical Co Ltd
SZSE:300723
Yipinhong Pharmaceutical Co Ltd
SZSE:300723
Price:
51.37
CNY
-10.82%
Market Closed
Market Cap:
23.2B
CNY
EV/EBITDA
Enterprise Value to EBITDA
Enterprise Value to EBITDA
-57.6
Current
35.7
Median
12.8
Industry
Lower
than median
Lower
than industry value
Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.
EV/EBITDA
=-57.6
Enterprise Value
/
24.6B CNY
EBITDA
-426.3m CNY
EV/EBITDA Forward Multiples
Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
EV/EBITDA
53.7
2-Years Forward
EV/EBITDA
45.6
3-Years Forward
EV/EBITDA
40.2
You don't have any saved screeners yet
